Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
Xudong ZhuRongpu LiangTianyun LanDongbing DingShengxin HuangJun ShaoZongheng ZhengTufeng ChenYong HuangJianpei LiuJanak L PathakHongbo WeiBo WeiPublished in: Journal for immunotherapy of cancer (2022)
TAMs in CRC tissue could turn into a potential therapeutic target for CRC treatment.